A Philadelphia founder has been using artificial intelligence for life sciences materials since 2015, long before the mainstream hype for the tech.

The purpose of the incorporation of this wholly owned subsidiary is to expand the biopharma products business in Europe.

Tata Midcap Growth Fund turns a Rs 1,000 monthly SIP into Rs 1 crore in 30 years. Explore its top holdings, risk profile, and ...

GIC Re on Monday posted a 17% decline in net profit to ₹2,183 crore for the fourth quarter ended March 2025. The state-owned ...

Acadia Pharmaceuticals ACAD shares surged 26.5% on Friday after the company announced that the U.S. District Court in ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare.

Aurobindo Pharma Ltd.’s proposed copies of Acadia Pharmaceuticals Inc.’s Nuplazid capsules infringe a patent for the Parkinson’s disease drug that won’t expire for more than 13 years, a federal judge ...

Aurobindo Pharma, through its wholly owned subsidiary Apitoria, launched ‘Auro Astra’ a leadership development initiative in collaboration with the Institute of Management Technology ...

Aurobindo Pharma subsidiary CuraTeQ Biologics s.r.o ... of the European Medicines Agency (EMA), the company had said the product is intended for the treatment of neutropenia and the mobilisation ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY ...